Guangdong low-cost policy to raise China price pressure
This article was originally published in Scrip
Executive Summary
As part of China's ongoing efforts to curb rising healthcare costs, the nation's most populous province, Guangdong, has recently adopted a controversial new scheme for the procurement of medicines, including essential products and national healthcare scheme-listed drugs (NHSDs).